Publisher： Blackwell Publishing
E-ISSN： 1097-0142|121|22|3929-3929
ISSN： 0008-543X
Source： Cancer, Vol.121, Iss.22, 2015-11, pp. : 3929-3929
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cetuximab: high response rates in metastatic colorectal cancer
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :
Access to resources
Recommend
Gemcitabine regimens improve response rates in colorectal cancer
Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. :
High costs of care for US colorectal cancer survivors
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 357, 2002-01 ,pp. :
Cancer still leading cause of death for US Hispanics
Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. :
Irinotecan 3-weekly schedule the winner in colorectal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 473, 2005-01 ,pp. :